hotspot -WSS

hotspot

author：fashion 2025-09-30 16:26:00 - browse：41895

Kevin Sayer, CEO of Dexcom Dexcom

For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin.

“We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer, CEO of Dexcom, told STAT. “This new product is going to be designed to address the needs of somebody with diabetes who’s not doing that, who has type 2 diabetes and is on other drugs.”

Continuous glucose monitoring is already well-established among people with type 1 diabetes, who rely on constant insulin therapy. The technology, which helps patients noninvasively monitor their blood sugar levels and control their insulin pump in real time, has grown rapidly in use over the years, culminating in a $5 billion market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Opioid cravings were reduced by anti

focus

WSS

Ukraine seeks to reclaim its role as a hub for clinical trials

PlayStation controller and acoustic messaging: How the missing Titanic tourist sub works

4 dead, 2 in stable condition in Philadelphia shooting: Police

ThunderShirts, dance parties and anxiety meds can help ease dogs' July Fourth dread

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

hotspot

hotspot

leisure time

Affirmative action in medical school literally saved lives

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

As demand for Covid shots wanes, Moderna seeks its next success

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation

Walensky prepares to leave CDC — and Congress — behind

Medicare Advantage enrollment hits roughly 33.4 million

After affirmative action ruling, medical educators look to 'holistic review'

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

hotspot

As AI regulations shape up, health tech startups beg for clarity

Abridge raises $150m as clinical notes automation market heats up

Medicare Advantage enrollment hits roughly 33.4 million

Obamacare plans could cover weight loss drugs

In 'major milestone,' FDA approves first cell therapy for solid tumors

1 dead, 9 hurt in July 4th fireworks explosion

focus

focus

focus

explore